ISAC Resources

Latest News

IJAA Free Access!

Read the January issue of IJAA for free!

Read More
ISAC Honorary Membership ...

Prof. Shaheen Mehtar announced as 2019's awardee!

Read More

The following are a list of publications written under the auspices of ISAC:

Influenza_Poster.pdf
Not sick enough to worry? "Flu-like" symptoms and work-related behaviour among healthcare workers and other professionals worldwide. 
Ermira Tartari*,Katja Saris*, Nikki Kenters, Kalisvar Marimuthu, Andreas Widmer, Peter Collignon, Vincent Cheng, Shuk Ching Wong, Tom Gottlieb, Eli Perencevich, Paul Tambyah, Benedetta Allegranzi, Angela Dramowski, Michael Edmond, Members of the ISAC-IPC working group, Andreas Voss On behalf of: ISAC, Infection Prevention and Control (IPC) Working Group
Control of Candida auris in healthcare institutions: outcome of an ISAC expert meeting
Kenters N, Kiernan M, Chowdhary A et al.
Int J Antimicrob Agents. Aug 2019 [Epub ahead of print]
Hot Topics on Vertebral Osteomyelitis from the International Society of Antimicrobial Chemotherapy.
Saeed K, Esposito S, Ascione T et al
Int J Antimicrob Agents. 2019 June [Epub ahead of print]
New Drugs for Multidrug-Resistant Gram-Negative Organisms: Time for Stewardship.
Jean SS, Gould IM, Lee WS et al.
Drugs. 2019 May;79(7):705-714
An update on Staphylococcus aureus infective endocarditis from the International Society of Antimicrobial Chemotherapy (ISAC).
Saeed K, Bal AM, Gould IM et al.
Int J Antimicrob Agents. 2019 Jan;53(1):9-15
Hot topics in necrotising skin and soft tissue infections.
Saeed K, Esposito S, Gould I et al.
Int J Antimicrob Agents. 2018 Jul;52(1):1-10
Panton-Valentine leukocidin-positive Staphylococcus aureus: a position statement from the International Society of Chemotherapy.
Saeed K, Gould I, Esposito S et al.
Int J Antimicrob Agents. 2018 Jan;51(1):16-25
Future trends in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infection: An in-depth review of newer antibiotics active against an enduring pathogen.
Bal AM, David MZ, Garau J et al .
J Glob Antimicrob Resist. 2017 Sep;10:295-303
Prosthetic joints: shining lights on challenging blind spots.
Saeed K, Dryden M, Bassetti M et al.
Int J Antimicrob Agents. 2017 Feb;49(2):153-161
Methicillin-resistant Staphylococcus aureus infections: A review of the currently available treatment options.
Purrello SM, Garau J, Giamarellos E et al.
J Glob Antimicrob Resist. 2016 Dec;7:178-186
Genomic insights into the emergence and spread of international clones of healthcare-, community- and livestock-associated meticillin-resistant Staphylococcus aureus: Blurring of the traditional definitions.
Bal AM, Coombs GW, Holden MTG et al.
J Glob Antimicrob Resist. 2016 Sep;6:95-101
Ten key points for the appropriate use of antibiotics in hospitalised patients: a consensus from the Antimicrobial Stewardship and Resistance Working Groups of the International Society of Chemotherapy.
Levy Hara G, Kanj SS, Pagani L et al.
Int J Antimicrob Agents. 2016 Sep;48(3):239-46
Hot topics in the diagnosis and management of skin and soft-tissue infections.
Esposito S, Bassetti M, Bonnet E et al.
Int J Antimicrob Agents. 2016 Jul;48(1):19-26
Preventing the introduction of meticillin-resistant Staphylococcus aureus into hospitals. 
Larsen J, David MZ, Vos MC et al.
J Glob Antimicrob Resist. 2014 Dec;2(4):260-268
Treatment options for methicillin-resistant Staphylococcus aureus (MRSA) infection: Where are we now?
Edwards B, Andini R, Esposito S et al.
J Glob Antimicrob Resist. 2014 Sep;2(3):133-140
Meticillin-resistant Staphylococcus aureus (MRSA) update: New insights into bacterial adaptation and therapeutic targets.
Purrello SM, Daum RS, Edwards GF et al.
J Glob Antimicrob Resist. 2014 Jun;2(2):61-69
MDRO Beijing Consensus Meeting Report: Global burden of multidrug-resistant organisms' current antimicrobial resistance problems in Asia-Pacific.
Gould IM, Wang GQ, Wu JJ et al.
J Glob Antimicrob Resist. 2014 Mar;2(1):7-9
Vancomycin in the treatment of meticillin-resistant Staphylococcus aureus (MRSA) infection: End of an era?
Bal AM, Garau J, Gould IM et al.
J Glob Antimicrob Resist. 2013 Mar;1(1):23-30
New insights into meticillin-resistant Staphylococcus aureus (MRSA) pathogenesis, treatment and resistance.
Gould IM, David MZ, Esposito S et al.
Int J Antimicrob Agents. 2012 Feb;39(2):96-104
Meticillin-resistant Staphylococcus aureus (MRSA): global epidemiology and harmonisation of typing methods.
Stefani S, Chung DR, Lindsay JA et al.
Int J Antimicrob Agents. 2012 Apr;39(4):273-82
Update on the prevention and control of community-acquired meticillin-resistant Staphylococcus aureus (CA-MRSA).
Skov R, Christiansen K, Dancer SJ et al.
Int J Antimicrob Agents. 2012 Mar;39(3):193-200
"Ten Commandments" for the Appropriate use of Antibiotics by the Practicing Physician in an Outpatient Setting.
Levy-Hara G, Amábile-Cuevas CF, Gould I et al.
Front Microbiol. 2011 Nov 24;2:230
Diagnosis and management of skin and soft-tissue infections (SSTI): a literature review and consensus statement on behalf of the Italian Society of Infectious Diseases and International Society of Chemotherapy.
Esposito S, Bassetti M, Borre S et al.
J Chemother. 2011 Oct;23(5):251-62
Meticillin-resistant Staphylococcus aureus (MRSA): screening and decolonisation.
Cookson B, Bonten MJ, Mackenzie FM et al.
Int J Antimicrob Agents. 2011 Mar;37(3):195-201
Management of serious meticillin-resistant Staphylococcus aureus infections: what are the limits?
Gould IM, Cauda R, Esposito S et al.
Int J Antimicrob Agents. 2011 Mar;37(3):202-9